FindTrial
Sign In

Ferrous sulfate tablets

DRUG9 trials

Sponsors

Watson Pharmaceuticals, American Regent, Inc., Norwegian University of Science and Technology, Auerbach Hematology Oncology Associates P C

Conditions

AnemiaAnemia, Iron-DeficiencyDepression, PostpartumIron Deficiency AnemiaIron Deficiency Anemia Secondary to IBD or Gastric BypassKidney Failure, ChronicPostpartum AnemiaPuerperal Disorders

Phase 2

Controlled Randomised Trial of Ferric Carboxymaltose and Oral Iron to Treat Postpartum Anemia
TerminatedNCT00929409
Norwegian University of Science and TechnologyAnemia, Iron-Deficiency, Depression, Postpartum, Puerperal Disorders
Start: 2009-06-30End: 2010-07-31Updated: 2012-02-17

Phase 3

VIT45 Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease
CompletedNCT00317239
American Regent, Inc.Anemia
Start: 2005-05-31End: 2007-08-31Updated: 2018-02-20
Safety and Efficacy of a Hematinic Agent in the Treatment of Postpartum Patients
CompletedNCT00354484
American Regent, Inc.Postpartum Anemia
Start: 2006-05-31End: 2007-01-31Updated: 2018-02-20
Comparison of the Safety and Efficacy of Intravenous Iron Versus Oral Iron in the Treatment of Anemia Secondary to Heavy Uterine Bleeding
CompletedNCT00395993
American Regent, Inc.Anemia
Start: 2005-05-31End: 2006-06-30Updated: 2018-02-20
Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia (IDA)
CompletedNCT00982007
American Regent, Inc.Iron Deficiency Anemia
Start: 2009-09-30End: 2011-08-31Updated: 2018-02-20
Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient
RecruitingNCT04268849
Auerbach Hematology Oncology Associates P CIron Deficiency Anemia
Start: 2020-02-27End: 2026-02-28Target: 104Updated: 2025-10-03

Phase 4

Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients Receiving Erythropoietic Agents
CompletedNCT00224042
Watson PharmaceuticalsAnemia, Iron-Deficiency, Kidney Failure, Chronic
Start: 2003-04-30Updated: 2012-03-29
Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients
CompletedNCT00224055
Watson PharmaceuticalsAnemia, Iron-Deficiency, Kidney Failure, Chronic
Start: 2003-04-30End: 2004-09-30Updated: 2012-03-29
Treatment Response of Injectafer vs Oral Iron to Baseline Hepcidin Levels in Patients With Iron Deficiency Anemia (IDA) Secondary to Inflammatory Bowel Disease (IBD) or Gastric Bypass
CompletedNCT02086968
American Regent, Inc.Iron Deficiency Anemia Secondary to IBD or Gastric Bypass
Start: 2014-01-01End: 2017-10-31Updated: 2020-09-17